Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

作者：Jeremy S Abramson, M. Lia Palomba, Leo I. Gordon, Matthew A. Lunning, Michael Wang, Jon Arnason, Amitkumar Mehta, Enkhtsetseg Purev, David G. Maloney, Charalambos Andreadis, Alison R. Sehgal, Scott R. Solomon, Nilanjan Ghosh, Tina Albertson, Jacob Garcia, Ana Kostić, Mary Mallaney, K. OGASAWARA, Kathryn J. Newhall, Yeonhee Kim, D. Li, Tanya Siddiqi · 发表于：The Lancet · 年份：2020 · DOI：10.1016/s0140-6736(20)31366-0 · 被引用次数：2412 · 研究领域：CAR-T cell therapy research、Lymphoma Diagnosis and Treatment、Cutaneous lymphoproliferative disorders research